Life Science News

- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2022 of $1.06 per share on the company's common stock. The dividend is payable on March 8, 2022 to shareholders of record at the close of business on February 22, 2022 . The ex-dividend date is February 18, 2022 .

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

(PRNewsfoto/Johnson & Johnson)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-announces-quarterly-dividend-for-first-quarter-2022-301452880.html

SOURCE Johnson & Johnson

News Provided by PR Newswire via QuoteMedia

JNJ
Sarama Resources Ltd

West African Gold Explorer & Developer, Sarama Resources, Lists on ASX, Raises A$8M

Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSXV:SWA) is pleased to announce that the Company’s securities have commenced trading on the Australian Securities Exchange (“ASX”) under the ASX code SRR following a strongly supported public offering which saw A$8M raised predominantly from a broad base of domestic and international institutional and sophisticated investors.